2. Signaling Pathways
  3. Others
  4. Others
  5. Others Agonist

Others Agonist

Others Agonists (72):

Cat. No. Product Name Effect Purity
  • HY-P99055
    Urelumab
    		Agonist 99.138%
    Urelumab, a fully human, non-ligand binding, CD137 agonist IgG4 monoclonal antibody, enhances T-cell and natural killer-cell antitumor activity, and may enhance cytotoxic activity of Rituximab (HY-P9913). Urelumab can be used for the research of diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and other types of non-Hodgkin lymphoma (NHL).
  • HY-P0059
    Teriparatide
    		Agonist 99.92%
    Teriparatide (Human parathyroid hormone-(1-34)) is a PTH1 receptor agonist. Teriparatide (Human parathyroid hormone-(1-34)) can be used for osteoporosis research.
  • HY-B1161
    Methoprene
    		Agonist ≥98.0%
    Methoprene, an insect juvenile growth hormone mimic, is a growth-regulating insecticide that manifests its toxicity to target organisms by acting as a juvenile hormone agonist.
  • HY-P1237
    C-Type Natriuretic Peptide (CNP) (1-22), human
    		Agonist 99.41%
    C-Type Natriuretic Peptide (CNP) (1-22), human, a 1-22 fragment of CNP, is a natriuretic peptide receptor B (NPR-B) agonist. C-Type Natriuretic Peptide (CNP) (1-22), human inhibits cAMP synthesis stimulated by the physiological agonists histamine and 5-HT or directly by Forskolin. CNP is a potent, endothelial-derived relaxant and growthinhibitory factor.
  • HY-149164
    BTB09089
    		Agonist 99.43%
    BTB09089 is a T cell death-associated gene 8 (TDAG8/GPR65) specific agonist. BTB09089 increases TDAG8 expression and regulates the cytokine production of T cells and macrophages.
  • HY-P0267
    Melanotan (MT)-II
    		Agonist 99.82%
    Melanotan (MT)-II, a synthetic melanocortin receptor agonist, is an injectable peptide hormone used to promote tanning.
  • HY-P2198
    PAMP-12(human, porcine)
    		Agonist
    PAMP-12(human, porcine) is a major component of immunoreactive (ir)-PAMP, is processed from the adrenomedullin precursor, is a potent hypotensive peptide and participates in cardiovascular control.
  • HY-W016868
    3-Chloro-5-hydroxybenzoic acid
    		Agonist 98.01%
    3-Chloro-5-hydroxybenzoic acid is a potent, orally active and selective lactate receptor GPR81 agonist, with an EC50 of 16 μM for human GPR81. 3-Chloro-5-hydroxybenzoic acid exhibits favorable in vivo effects on lipolysis in a mouse model of obesity.
  • HY-P0168
    Cibinetide
    		Agonist 99.68%
    Cibinetide (ARA290) is an EPO-derivative, acting as a specific agonist of erythropoietin/CD131 heteroreceptor, and used for neurological disease treatment.
  • HY-P99046
    Selicrelumab
    		Agonist
    Selicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study.
  • HY-P1237A
    C-Type Natriuretic Peptide (CNP) (1-22), human TFA
    		Agonist 98.10%
    C-Type Natriuretic Peptide (CNP) (1-22), human (TFA),a 1-22 fragment of CNP, is a natriuretic peptide receptor B (NPR-B) agonist. C-Type Natriuretic Peptide (CNP) (1-22), human (TFA) inhibits cAMP synthesis stimulated by the physiological agonists histamine and 5-HT or directly by Forskolin. CNP is a potent, endothelial-derived relaxant and growthinhibitory factor.
  • HY-P3325
    P8RI
    		Agonist 99.70%
    P8RI (D-P8RI) is a biomimetic peptide of CD31 and a CD31 agonist. P8RI binds to the juxtamembrane amino acid sequence of the ectodomain of CD31, shows an immunosuppressive effect through restoration of the CD31 inhibitory pathway.
  • HY-P0003
    Nesiritide
    		Agonist 99.71%
    Nesiritide (Brain Natriuretic Peptide-32 human) is an agonist of natriuretic peptide receptors (NPRs), with Kd values of 7.3 and 13 pM for NPR-A and NPR-C, respectively.
  • HY-P1211
    Adrenocorticotropic Hormone (ACTH) (1-39), human
    		Agonist 99.09%
    Adrenocorticotropic Hormone (ACTH) (1-39), human is a melanocortin receptor agonist.
  • HY-110329
    ML179
    		Agonist 99.83%
    ML179 (SR-1309) is a inverse LRH1 (Liver receptor homologue-1) agonist with IC50 of 320 nM. ML179 shows anti-proliferation activity in MDA-MB-231 cells. ML179 has the potential for the research of ER-negative breast cancer.
  • HY-P3304
    MR 409
    		Agonist 99.51%
    MR 409 is a selected growth hormone-releasing hormone (GHRH) agonist. MR 409 has remarkable neuroprotective effects through enhancing endogenous neurogenesis in cerebral ischemic mice. MR 409 also inhibits the in vivo growth of lung cancer.
  • HY-P5411
    OVA-T4 Peptide
    		Agonist 99.59%
    OVA-T4 Peptide (SIITFEKL, OVA (257-264) Variant) is a biological active peptide. (T4 peptide (SIITFEKL) is a variant of the agonist ovalbumin (OVA) peptide (257-264), SIINFEKL. OVA Peptide is a class I (Kb)-restricted peptide epitope of ovalbumin presented by the class I MHC (major histocompatibility complex) molecule, H-2Kb (class I genes of the mouse MHC).)
  • HY-155318A
    GPR3 agonist-2
    		Agonist 98.80%
    GPR3 agonist-2(compound 32) is a potent full agonist of G protein-coupled receptor 3, with the IC50of 260 nM.
  • HY-N6629
    3'-Methoxyflavonol
    		Agonist 99.92%
    3'-Methoxyflavonol is a selective agonist of neuromedin U 2 receptor (NMU2R).
  • HY-153265
    TAS2R14 agonist-2
    		Agonist 99.91%
    TAS2R14 agonist-2 (compound 28.1) is a potent and selective TAS2R14 inhibitor with an EC50 value of 72 nM.